Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival

J Biol Chem. 2005 Feb 11;280(6):4117-24. doi: 10.1074/jbc.M411200200. Epub 2004 Dec 7.

Abstract

Glucocorticoid receptor (GR) activation has recently been shown to inhibit apoptosis in breast epithelial cells. We have previously described a group of genes that is rapidly up-regulated in these cells following dexamethasone (Dex) treatment. In an effort to dissect the mechanisms of GR-mediated breast epithelial cell survival, we now examine the molecular events downstream of GR activation. Here we show that GR activation leads to both the rapid induction of MAPK phosphatase-1 (MKP-1) mRNA and its sustained expression. Induction of the MKP-1 protein in the MCF10A-Myc and MDA-MB-231 breast epithelial cell lines was also seen. Paclitaxel treatment resulted in MAPK activation and apoptosis of MDA-MB-231 breast cancer cells, and both processes were inhibited by Dex pretreatment. Furthermore, induction of MKP-1 correlated with the inhibition of extracellular signal-regulated kinase (ERK1/2) and c-Jun N-terminal kinase (JNK) activity, whereas p38 activity was minimally affected. Blocking Dex-induced MKP-1 induction using small interfering RNA increased ERK1/2 and JNK phosphorylation and decreased cell survival. ERK1/2 and JNK inactivation was associated with Ets-like transcription factor-1 (ELK-1) dephosphorylation. To explore the gene expression changes that occur downstream of ELK-1 dephosphorylation, we used a combination of temporal gene expression data and promoter element analyses. This approach revealed a previously unrecognized transcriptional target of ELK-1, the human tissue plasminogen activator (tPA). We verified the predicted ELK-1--> tPA transcriptional regulatory relationship using a luciferase reporter assay. We conclude that GR-mediated MAPK inactivation contributes to cell survival and that the potential transcriptional targets of this inhibition can be identified from large scale gene array analysis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Motifs
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Apoptosis
  • Blotting, Northern
  • Blotting, Western
  • Breast / metabolism
  • Cell Cycle Proteins / metabolism
  • Cell Cycle Proteins / physiology*
  • Cell Line, Tumor
  • Cell Survival
  • DNA-Binding Proteins / biosynthesis
  • Down-Regulation
  • Dual Specificity Phosphatase 1
  • Enzyme Activation
  • Gene Expression Regulation, Neoplastic
  • Genes, Reporter
  • Humans
  • Immediate-Early Proteins / metabolism
  • Immediate-Early Proteins / physiology*
  • JNK Mitogen-Activated Protein Kinases / biosynthesis
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Luciferases / metabolism
  • MAP Kinase Kinase 4
  • MAP Kinase Signaling System*
  • Mitogen-Activated Protein Kinase 1 / biosynthesis
  • Mitogen-Activated Protein Kinase 3 / biosynthesis
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Mitogen-Activated Protein Kinases / metabolism*
  • Models, Biological
  • Oligonucleotide Array Sequence Analysis
  • Paclitaxel / pharmacology*
  • Phosphoprotein Phosphatases / metabolism
  • Phosphoprotein Phosphatases / physiology*
  • Phosphorylation
  • Protein Binding
  • Protein Phosphatase 1
  • Protein Tyrosine Phosphatases / metabolism
  • Protein Tyrosine Phosphatases / physiology*
  • Proto-Oncogene Proteins / biosynthesis
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / metabolism
  • Receptors, Glucocorticoid / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Tissue Plasminogen Activator / metabolism
  • Transcription Factors / biosynthesis
  • Transcription, Genetic
  • Transfection
  • ets-Domain Protein Elk-1
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Antineoplastic Agents, Phytogenic
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • ELK1 protein, human
  • Immediate-Early Proteins
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • RNA, Small Interfering
  • Receptors, Glucocorticoid
  • Transcription Factors
  • ets-Domain Protein Elk-1
  • Luciferases
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • Mitogen-Activated Protein Kinase Kinases
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 1
  • DUSP1 protein, human
  • Dual Specificity Phosphatase 1
  • Protein Tyrosine Phosphatases
  • Tissue Plasminogen Activator
  • Paclitaxel